FDA experts backed the administration of a second dose of the Johnson & Johnson vaccine
All 19 experts voting in the Advisory Committee on Vaccines and Related Biological Products expressed a positive opinion. Members of the FDA’s advisory body agreed that in view of the lower level of protection afforded by the previously single-dose vaccine compared to the Pfizer and Moderna preparations, the use of a second dose is warranted. … Read more